PABPC1 and lung cancer: However, in other studies, PABPC1 over-expression was described in prostate tumors [47], hepatocellular carcinoma [48], superficial bladder cancer [49], and lung cancer [50]; in the latter report the authors suggested the participation of the translation initiation complex in the tumorigenesis of lung cancer.